USPTO serial 79284994
ALTHEIA SCIENCE TOWARDS CURATIVE MEDICINE
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Dec 8, 2020
- Examiner
- O'BRIEN, JENNIFER LYNN
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with ALTHEIA SCIENCE TOWARDS CURATIVE MEDICINE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $797*
Plus Government fees of $975
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Alexander Lazouski
Alexander Lazouski LAZOUSKI IP LLCSUITE 1, 14726 BOWFIN TER.LAKEWOOD RANCH, FL 34202UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Reagents for use in medical genetic testing; food for diabetics, namely, dietetic foods adapted for medical use; anti-diabetic preparations; anti-diabetic pharmaceuticals; pharmaceutical preparations for treating diabetes; pharmaceutical preparations for the prevention of diabetes; chemical preparations for pharmaceutical or medical purposes, namely, for the diagnosis of diabetes; pharmaceutical preparations for the treatment of multiple sclerosis; pharmaceutical preparations for regulating the immune system; pharmaceutical drugs in the nature of pharmaceutical preparations for the treatment of autoimmune diseases, rare disease and cancers; pharmaceutical preparations for use in hematology, namely, for the treatment of autoimmune diseases, rare disease and cancers; stem cells for medical or veterinary use; stem cells for medical purposes; surgical implants comprising living tissue grown from stem cells; drugs in the nature of pharmaceutical preparations for treating diabetes; drugs in the nature of pharmaceutical preparations for treating multiple sclerosis | ACTIVE | — |
| 042 | Genetic research; genetic engineering services; Genetic testing for scientific research purposes, namely, genetic fingerprinting; scientific research in the field of genetics and genetic engineering; scientific research relating to genetics; advisory services relating to gene therapy research; research in the field of gene therapy; stem cell research; all the above-mentioned services in the field of autoimmune diseases, rare disease and cancers | ACTIVE | — |
| 044 | Genetic testing for medical purposes; medical and health services relating to DNA, genetics and genetic testing; therapy services, namely, speech therapy services, medical, physical rehabilitation and physical therapy services, cognitive therapy services; Medical diabetes screening services; medical services in the field of diabetes; providing information via the Internet in the field of diabetes; medical laboratory services for the analysis of blood samples taken from patients, namely, medical analysis services for diagnostic and treatment purposes provided by medical laboratories; stem cell storage, namely, tissue bank services; medical services relating to the removal, treatment and processing of stem cells; therapy for diabetes, namely, medical, physical rehabilitation and physical therapy services; therapy for multiple sclerosis, namely, medical, physical rehabilitation and physical therapy services; lymphocyte gene therapy, for therapeutic purposes; haemopoietic stem cell gene therapy, for therapeutic purposes; all the above-mentioned services in the field of autoimmune diseases, rare disease and cancers | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by ALTHEIA SCIENCE S.r.L.
- Other trademarks owned by ALTHEIA SCIENCE S.r.L.
- Other trademarks owned by ALTHEIA SCIENCE S.r.L.
- Other trademarks in Class 005
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named ALTHEIA SCIENCE TOWARDS CURATIVE MEDICINE
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Dec 8, 2025 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| May 11, 2021 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Mar 11, 2021 | XXSS | GENERIC MADRID TRANSACTION SENT TO IB | — |
| Mar 11, 2021 | XXCR | GENERIC MADRID TRANSACTION CREATED | — |
| Mar 8, 2021 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Dec 8, 2020 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Sep 22, 2020 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Sep 22, 2020 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Sep 2, 2020 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Aug 14, 2020 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jul 28, 2020 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jul 27, 2020 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 27, 2020 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 3, 2020 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jun 15, 2020 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jun 15, 2020 | RFRR | REFUSAL PROCESSED BY MPU | — |
| May 26, 2020 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| May 25, 2020 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 18, 2020 | DOCK | ASSIGNED TO EXAMINER | — |
| May 12, 2020 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| May 8, 2020 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| May 7, 2020 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |